The Patent Finder

Context Biopharma Inc.

Also on record
Records under this name other than the patents Context Biopharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 3 of 3 · Back to Context Biopharma Inc.

PatentTitleStatus Expires Confidence
US 10,786,461Onapristone extended-release compositions and methods
Lapsed on the fee record
Ended Sep 29, 2024 · From the USPTO record
Lapsed on the fee recordEnded Sep 29, 2024From the USPTO record
US 10,548,905Amorphous onapristone compositions and methods of making the same
Lapsed on the fee record
Ended Feb 4, 2024 · From the USPTO record
Lapsed on the fee recordEnded Feb 4, 2024From the USPTO record
US 9,193,757Onapristone polymorphic forms and methods of use
Lapsed on the fee record
Ended Nov 24, 2023 · From the USPTO record
Lapsed on the fee recordEnded Nov 24, 2023From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited